Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Article
  • Published:

Novel electric power-driven hydrodynamic injection system for gene delivery: safety and efficacy of human factor IX delivery in rats

Abstract

The development of a safe and reproducible gene delivery system is an essential step toward the clinical application of the hydrodynamic gene delivery (HGD) method. For this purpose, we have developed a novel electric power-driven injection system called the HydroJector-EM, which can replicate various time–pressure curves preloaded into the computer program before injection. The assessment of the reproducibility and safety of gene delivery system in vitro and in vivo demonstrated the precise replication of intravascular time–pressure curves and the reproducibility of gene delivery efficiency. The highest level of luciferase expression (272 pg luciferase per mg of proteins) was achieved safely using the time–pressure curve, which reaches 30 mm Hg in 10 s among various curves tested. Using this curve, the sustained expression of a therapeutic level of human factor IX protein (>500 ng ml−1) was maintained for 2 months after the HGD of the pBS-HCRHP-FIXIA plasmid. Other than a transient increase in liver enzymes that recovered in a few days, no adverse events were seen in rats. These results confirm the effectiveness of the HydroJector-EM for reproducible gene delivery and demonstrate that long-term therapeutic gene expression can be achieved by automatic computer-controlled hydrodynamic injection that can be performed by anyone.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5

Similar content being viewed by others

References

  1. The Journal of Gene Medicine. Gene therapy clinical trials worldwide. http://www.wiley.com/legacy/wileychi/genmed/clinical/ (accessed on 28 August 2012).

  2. Liu F, Song Y, Liu D . Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA. Gene Therapy 1999; 6: 1258–1266.

    Article  CAS  Google Scholar 

  3. Zhang G, Budker V, Wolff JA . High levels of foreign gene expression in hepatocytes after tail vein injections of naked plasmid DNA. Hum Gene Ther 1999; 10: 1735–1737.

    Article  CAS  Google Scholar 

  4. Suda T, Liu D . Hydrodynamic gene delivery: its principles and applications. Mol Ther 2007; 15: 2063–2069.

    Article  CAS  Google Scholar 

  5. Herweijer H, Wolff JA . Gene therapy progress and prospects: hydrodynamic gene delivery. Gene Therapy 2007; 14: 99–107.

    Article  CAS  Google Scholar 

  6. Kamimura K, Liu D . Physical approaches for nucleic acid delivery to liver. AAPS J 2008; 10: 589–595.

    Article  CAS  Google Scholar 

  7. Kamimura K, Suda T, Zhang G, Liu D . Advances in gene delivery systems. Pharm Med 2011; 25: 293–306.

    Article  Google Scholar 

  8. Bonamassa B, Hai L, Liu D . Hydrodynamic gene delivery and its applications in pharmaceutical research. Pharm Res 2011; 28: 694–701.

    Article  CAS  Google Scholar 

  9. Suda T, Gao X, Stolz DB, Liu D . Structural impact of hydrodynamic injection on mouse liver. Gene Therapy 2007; 14: 129–137.

    Article  CAS  Google Scholar 

  10. Zhang G, Song YK, Liu D . Long-term expression of human alpha1-antitrypsin gene in mouse liver achieved by intravenous administration of plasmid DNA using a hydrodynamics-based procedure. Gene Therapy 2000; 7: 1344–1349.

    Article  CAS  Google Scholar 

  11. Zhang G, Gao X, Song YK, Vollmer R, Stolz DB, Gasiorowski JZ et al. Hydroporation as the mechanism of hydrodynamic delivery. Gene Therapy 2004; 11: 675–682.

    Article  CAS  Google Scholar 

  12. Zhou T, Kamimura K, Zhang G, Liu D . Intracellular gene transfer in rats by tail vein injection of plasmid DNA. AAPS J 2010; 12: 692–698.

    Article  CAS  Google Scholar 

  13. Eastman SJ, Baskin KM, Hodges BL, Chu Q, Gates A, Dreusicke R et al. Development of catheter-based procedures for transducing the isolated rabbit liver with plasmid DNA. Hum Gene Ther 2002; 13: 2065–2077.

    Article  CAS  Google Scholar 

  14. Yoshino H, Hashizume K, Kobayashi E . Naked plasmid DNA transfer to the porcine liver using rapid injection with large volume. Gene Therapy 2006; 13: 1696–1702.

    Article  CAS  Google Scholar 

  15. Alino SF, Herrero MJ, Noguera I, Dasi F, Sanchez M . Pig liver gene therapy by noninvasive interventionist catheterism. Gene Therapy 2007; 14: 334–343.

    Article  CAS  Google Scholar 

  16. Fabre JW, Grehan A, Whitehorne M, Sawyer GJ, Dong X, Salehi S et al. Hydrodynamic gene delivery to the pig liver via an isolated segment of the inferior vena cava. Gene Therapy 2008; 15: 452–462.

    Article  CAS  Google Scholar 

  17. Kamimura K, Suda T, Xu W, Zhang G, Liu D . Image-guided, lobe-specific hydrodynamic gene delivery to swine liver. Mol Ther 2009; 17: 491–499.

    Article  CAS  Google Scholar 

  18. Kamimura K, Guisheng Z, Liu D . Image-guided, intravascular hydrodynamic gene delivery to skeletal muscle in pigs. Mol Ther 2010; 18: 93–100.

    Article  CAS  Google Scholar 

  19. Herrero MJ, Sabater L, Guenechea G, Sendra L, Montilla AI, Abargues R et al. DNA delivery to ‘ex vivo’ human liver segments. Gene Therapy 2012; 9: 504–512.

    Article  Google Scholar 

  20. Suda T, Suda K, Liu D . Computer-assisted hydrodynamic gene delivery. Mol Ther 2008; 16: 1098–1104.

    Article  CAS  Google Scholar 

  21. Miao CH, Thompson AR, Loeb K, Ye X . Long-term and therapeutic-level hepatic gene expression of human factor IX after naked plasmid transfer in vivo. Mol Ther 2001; 3: 947–957.

    Article  CAS  Google Scholar 

  22. Miao CH, Ye X, Thompson AR . High-level factor VIII gene expression in vivo achieved by nonviral liver-specific gene therapy vectors. Hum Gene Ther 2003; 14: 1297–1305.

    Article  CAS  Google Scholar 

  23. Miao CH, Brayman AA, Loeb KR, Ye P, Zhou L, Mourad P et al. Ultrasound enhances gene delivery of human factor IX plasmid. Hum Gene Ther 2005; 16: 893–905.

    Article  CAS  Google Scholar 

  24. Tuddenham E . Gene therapy for haemophilia B. Haemophilia 2012; 18 (Suppl 4): 13–17.

    Article  Google Scholar 

  25. Benveniste O . Gene therapy, an ongoing revolution. Blood 2012; 119: 2973–2974.

    Article  CAS  Google Scholar 

  26. Brunetti-Pierri N, Liou A, Patel P, Palmer D, Grove N, Finegold M et al. Balloon catheter delivery of helper-dependent adenoviral vector results in sustained, therapeutic hFIX expression in Rhesus macaques. Mol Ther 2012; 20: 1863–1870.

    Article  CAS  Google Scholar 

  27. Schuttrumpf J, Milanov P, Abriss D, Roth S, Tonn T, Seifried E . Transgene loss and changes in the promoter methylation status as determinants for expression duration in nonviral gene transfer for factor IX. Hum Gene Ther 2011; 22: 101–106.

    Article  Google Scholar 

  28. Scott DW, Lozier JN . Gene therapy for haemophilia: prospects and challenges to prevent or reverse inhibitor formation. Br J Haematol 2012; 156: 295–302.

    Article  CAS  Google Scholar 

  29. Vollmar B, Menger MD . The hepatic microcirculation: mechanistic contributions and therapeutic targets in liver injury and repair. Physiol Rev 2009; 89: 1269–1339.

    Article  CAS  Google Scholar 

  30. Brunetti-Pierri N, Stapleton GE, Law M, Breinholt J, Palmer DJ, Zuo Y et al. Efficient, long-term hepatic gene transfer using clinically relevant HDAd doses by balloon occlusion catheter delivery in nonhuman primates. Mol Ther 2009; 17: 327–333.

    Article  CAS  Google Scholar 

  31. Vrekoussis T, Chaniotis V, Navrozoglou I, Dousias V, Pavlakis K, Stathopoulos EN et al. Image analysis of breast cancer immunohistochemistry-stained sections using ImageJ: an RGB-based model. Anticancer Res 2009; 29: 4995–4998.

    CAS  PubMed  Google Scholar 

Download references

Acknowledgements

This work was supported in part by JSPS Grants 22890064, 23790595, The Sumitomo Foundation Grant 100033 and Takeda Science Foundation Grant to KK. The authors acknowledge Takao Tsuchida, Division of Gastroenterology and Hepatology, Niigata University, for his excellent assistance for histological stainings. The authors would like to thank Nobuyoshi Fujisawa, Minoru Tanaka and all staff members in Division of Laboratory Animal Resources in Niigata University for the excellent assistance for animal care. We thank Enago for the English language review.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to K Kamimura.

Ethics declarations

Competing interests

The authors declare no conflict of interest.

Additional information

Supplementary Information accompanies the paper on Gene Therapy website

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Cite this article

Yokoo, T., Kamimura, K., Suda, T. et al. Novel electric power-driven hydrodynamic injection system for gene delivery: safety and efficacy of human factor IX delivery in rats. Gene Ther 20, 816–823 (2013). https://doi.org/10.1038/gt.2013.2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/gt.2013.2

Keywords

This article is cited by

Search

Quick links